{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:36:01Z","timestamp":1792647361994,"version":"4.5.0"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T00:00:00Z","timestamp":1730764800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100001321","name":"National Research Foundation","doi-asserted-by":"publisher","award":["NRF- CRP27-2021-0002"],"award-info":[{"award-number":["NRF- CRP27-2021-0002"]}],"id":[{"id":"10.13039\/501100001321","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["EQU202103012588"],"award-info":[{"award-number":["EQU202103012588"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,1,3]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Non-tuberculous mycobacteria (NTM) infection presents a growing global health problem and requires new antibiotics targeting enzymes that are essential for the pathogens under various metabolic conditions, with high target specificity, good solubility and with attractive combinatory potency.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>SQ31f was synthesized by a simplified synthesis protocol, and its effect on growth inhibition of fast- and slow-growing NTM and clinical isolates, whole-cell ATP depletion, ex vivo macrophages and its potency in combination with other antibiotics were evaluated. Molecular docking studies were employed to assess SQ31f\u2019s binding mode.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>We present- squaramide SQ31f as a novel anti-NTM inhibitor targeting the NTM F1FO-ATP synthase, essential for ATP formation, regulation of ATP homeostasis and proton motive force under multiple growth conditions. The potency of SQ31f in growth inhibition of fast- and slow-growing NTM and clinical isolates correlates with whole-cell ATP depletion, which is not caused by altered oxygen consumption. SQ31f\u2019s high aqueous solubility enables binding to the waterfilled cytosolic proton half channel in the subunits a\u2013c interface of the FO domain. As presented for the fast-growing Mycobacterium abscessus, the compound is active against intracellular-residing M. abscessus. Importantly, SQ31f shows an additive effect of the anti-M. abscessus drugs clofazimine, rifabutin or amikacin, and an attractive potentiation of linezolid, clarithromycin, or the oral pair tebipenem and avibactam.<\/jats:p>\n               <\/jats:sec>\n               <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>SQ31f represents an attractive inhibitor to tackle the issues associated with NTM drug tolerance and toxicity. Its combinatory potency with anti-M. abscessus drugs holds potential for overcoming resistance, while also reducing intensive compound synthesis and associated costs.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1093\/jac\/dkae406","type":"journal-article","created":{"date-parts":[[2024,11,5]],"date-time":"2024-11-05T15:51:53Z","timestamp":1730821913000},"page":"270-280","source":"Crossref","is-referenced-by-count":10,"title":["SQ31f is a potent non-tuberculous mycobacteria antibiotic by specifically targeting the mycobacterial F-ATP synthase"],"prefix":"10.1093","volume":"80","author":[{"given":"Priya","family":"Ragunathan","sequence":"first","affiliation":[{"name":"School of Biological Sciences, Nanyang Technological University , 60 Nanyang Drive, Singapore 637551 ,","place":["Republic of Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patcharaporn","family":"Sae-Lao","sequence":"additional","affiliation":[{"name":"School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University , 21 Nanyang Link, Singapore 637371 ,","place":["Republic of Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaravadhi","family":"Harikishore","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, Nanyang Technological University , 60 Nanyang Drive, Singapore 637551 ,","place":["Republic of Singapore"]},{"name":"School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University , 21 Nanyang Link, Singapore 637371 ,","place":["Republic of Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9026-5333","authenticated-orcid":false,"given":"Wassim","family":"Daher","sequence":"additional","affiliation":[{"name":"Centre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Universit\u00e9 de Montpellier , 1919 route de Mende, 34293 Montpellier ,","place":["France"]},{"name":"INSERM, IRIM , 34293 Montpellier ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Roquet-Ban\u00e8res","sequence":"additional","affiliation":[{"name":"Centre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Universit\u00e9 de Montpellier , 1919 route de Mende, 34293 Montpellier ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6604-4458","authenticated-orcid":false,"given":"Laurent","family":"Kremer","sequence":"additional","affiliation":[{"name":"Centre National de la Recherche Scientifique UMR 9004, Institut de Recherche en Infectiologie de Montpellier (IRIM), Universit\u00e9 de Montpellier , 1919 route de Mende, 34293 Montpellier ,","place":["France"]},{"name":"INSERM, IRIM , 34293 Montpellier ,","place":["France"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick W","family":"Bates","sequence":"additional","affiliation":[{"name":"School of Chemistry, Chemical Engineering and Biotechnology, Nanyang Technological University , 21 Nanyang Link, Singapore 637371 ,","place":["Republic of Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerhard","family":"Gr\u00fcber","sequence":"additional","affiliation":[{"name":"School of Biological Sciences, Nanyang Technological University , 60 Nanyang Drive, Singapore 637551 ,","place":["Republic of Singapore"]},{"name":"Bioinformatics Institute, Agency for Science, Technology and Research (A*STAR) , 30 Biopolis Str., #07-01 Matrix, Singapore 138671 ,","place":["Republic of Singapore"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,11,5]]},"reference":[{"key":"2025010309481844400_dkae406-B1","doi-asserted-by":"publisher","first-page":"1502","DOI":"10.1016\/j.drudis.2018.04.001","article-title":"NTM drug discovery: status, gaps and the way forward","volume":"23","author":"Wu","year":"2018","journal-title":"Drug Discov Today"},{"key":"2025010309481844400_dkae406-B2","doi-asserted-by":"publisher","first-page":"2179","DOI":"10.3389\/fmicb.2018.02179","article-title":"The role of antibiotic-target-modifying and antibiotic-modifying enzymes in Mycobacterium abscessus drug resistance","volume":"9","author":"Luthra","year":"2018","journal-title":"Front Microbiol"},{"key":"2025010309481844400_dkae406-B3","doi-asserted-by":"publisher","first-page":"392","DOI":"10.1038\/s41579-020-0331-1","article-title":"Non-tuberculous mycobacteria and the rise of Mycobacterium abscessus","volume":"18","author":"Johansen","year":"2020","journal-title":"Nat Rev Microbiol"},{"key":"2025010309481844400_dkae406-B4","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.3389\/fmicb.2018.01145","article-title":"Glycopeptidolipids, a double-edged sword of the Mycobacterium abscessus complex","volume":"9","author":"Gutierrez","year":"2018","journal-title":"Front Microbiol"},{"key":"2025010309481844400_dkae406-B5","doi-asserted-by":"publisher","first-page":"5023","DOI":"10.1128\/JB.187.14.5023-5028.2005","article-title":"The F1Fo-ATP synthase of Mycobacterium smegmatis is essential for growth","volume":"187","author":"Tran","year":"2005","journal-title":"J Bacteriol"},{"key":"2025010309481844400_dkae406-B6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1378\/chest.14-2764","article-title":"Preliminary results of bedaquiline as salvage therapy for patients with non-tuberculous mycobacterial lung disease","volume":"148","author":"Philley","year":"2015","journal-title":"Chest"},{"key":"2025010309481844400_dkae406-B7","doi-asserted-by":"publisher","first-page":"e01225-17","DOI":"10.1128\/AAC.01225-17","article-title":"Bedaquiline inhibits the ATP synthase in Mycobacterium abscessus and is effective in infected zebrafish","volume":"61","author":"Dupont","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2025010309481844400_dkae406-B8","doi-asserted-by":"publisher","first-page":"e02404-19","DOI":"10.1128\/AAC.02404-19","article-title":"TBAJ-876, a 3,5-dialkoxypyridine analogue of bedaquiline, is active against Mycobacterium abscessus","volume":"64","author":"Sarathy","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2025010309481844400_dkae406-B9","doi-asserted-by":"publisher","first-page":"e0001822","DOI":"10.1128\/aac.00018-22","article-title":"Anti-Mycobacterium abscessus activity of tuberculosis F-ATP synthase inhibitor GaMF1","volume":"66","author":"Ragunathan","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2025010309481844400_dkae406-B10","doi-asserted-by":"publisher","first-page":"6308","DOI":"10.1111\/febs.16536","article-title":"Atomic solution structure of Mycobacterium abscessus F-ATP synthase subunit epsilon and identification of Ep1MabF1 as a targeted inhibitor","volume":"289","author":"Shin","year":"2022","journal-title":"FEBS J"},{"key":"2025010309481844400_dkae406-B11","doi-asserted-by":"publisher","first-page":"105618","DOI":"10.1016\/j.jbc.2023.105618","article-title":"High efficacy of the F-ATP synthase inhibitor TBAJ-5307 against nontuberculous mycobacteria in vitro and in vivo","volume":"300","author":"Ragunathan","year":"2024","journal-title":"J Biol Chem"},{"key":"2025010309481844400_dkae406-B12","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.pbiomolbio.2019.11.006","article-title":"Unique structural and mechanistic properties of mycobacterial F-ATP synthases: implications for drug design","volume":"152","author":"Kamariah","year":"2020","journal-title":"Prog Biophys Mol Biol"},{"key":"2025010309481844400_dkae406-B13","doi-asserted-by":"publisher","first-page":"e2111899118","DOI":"10.1073\/pnas.2111899118","article-title":"Structure of the ATP synthase from Mycobacterium smegmatis provides targets for treating tuberculosis","volume":"118","author":"Montgomery","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025010309481844400_dkae406-B14","doi-asserted-by":"publisher","first-page":"e0105622","DOI":"10.1128\/aac.01056-22","article-title":"Structural elements involved in ATP hydrolysis inhibition and ATP synthesis of tuberculosis and nontuberculous mycobacterial F-ATP synthase decipher new targets for inhibitors","volume":"66","author":"Wong","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2025010309481844400_dkae406-B15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s10863-012-9486-4","article-title":"Solution structure of subunit \u03b3 (\u03b31-204) of the Mycobacterium tuberculosis F-ATP synthase and the unique loop of \u03b3165-178, representing a novel TB drug target","volume":"45","author":"Priya","year":"2013","journal-title":"J Bioenerg Biomembr"},{"key":"2025010309481844400_dkae406-B16","doi-asserted-by":"publisher","first-page":"11262","DOI":"10.1074\/jbc.M117.784959","article-title":"The uniqueness of subunit \u03b1 of mycobacterial F-ATP synthases: an evolutionary variant for niche adaptation","volume":"292","author":"Ragunathan","year":"2017","journal-title":"J Biol Chem"},{"key":"2025010309481844400_dkae406-B17","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1126\/science.1106753","article-title":"A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis","volume":"307","author":"Andries","year":"2005","journal-title":"Science"},{"key":"2025010309481844400_dkae406-B18","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.1016\/j.bmc.2019.02.026","article-title":"3,5-Dialkoxypyridine analogues of bedaquiline are potent antituberculosis agents with minimal inhibition of the hERG channel","volume":"27","author":"Sutherland","year":"2019","journal-title":"Bioorg Med Chem"},{"key":"2025010309481844400_dkae406-B19","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/s41586-020-3004-3","article-title":"Structure of mycobacterial ATP synthase bound to the tuberculosis drug bedaquiline","volume":"589","author":"Guo","year":"2021","journal-title":"Nature"},{"key":"2025010309481844400_dkae406-B20","doi-asserted-by":"publisher","first-page":"e113687","DOI":"10.15252\/embj.2023113687","article-title":"Mechanism of mycobacterial ATP synthase inhibition by squaramides and second generation diarylquinolines","volume":"42","author":"Courbon","year":"2023","journal-title":"EMBO J"},{"key":"2025010309481844400_dkae406-B21","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1016\/j.crstbi.2022.09.001","article-title":"Binding properties of the anti-TB drugs bedaquiline and TBAJ-876 to a mycobacterial F-ATP synthase","volume":"4","author":"Krah","year":"2022","journal-title":"Curr Res Struct Biol"},{"key":"2025010309481844400_dkae406-B22","doi-asserted-by":"publisher","first-page":"149249","DOI":"10.1016\/j.bbrc.2023.149249","article-title":"Variations of the Mycobacterium abscessus F-ATP synthase subunit a-c interface alter binding and potency of the anti-TB drug bedaquiline","volume":"690","author":"Krah","year":"2024","journal-title":"Biochem Biophys Res Commun"},{"key":"2025010309481844400_dkae406-B23","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1021\/acs.jmedchem.6b01358","article-title":"Discovery of imidazo[1,2-a]pyridine ethers and squaramides as selective and potent inhibitors of mycobacterial adenosine triphosphate (ATP) synthesis","volume":"60","author":"Tantry","year":"2017","journal-title":"J Med Chem"},{"key":"2025010309481844400_dkae406-B24","volume-title":"Schr\u00f6dinger Release 2020-4: Maestro, Force Fields, Macromodel, Prime, Protein Preparation Wizard, LigPrep, Glide","author":"Schr\u00f6dinger LLC","year":"2019"},{"key":"2025010309481844400_dkae406-B25","doi-asserted-by":"publisher","first-page":"2477","DOI":"10.1021\/jo00246a016","article-title":"Synthesis of 4-substituted-3-alkoxy-3-cyclobutene-1,2-diones","volume":"53","author":"Reed","year":"1988","journal-title":"J Org Chem"},{"key":"2025010309481844400_dkae406-B26","doi-asserted-by":"publisher","first-page":"e00388-17","DOI":"10.1128\/genomeA.00388-17","article-title":"Draft genome sequence of Mycobacterium abscessus bamboo","volume":"5","author":"Yee","year":"2017","journal-title":"Genome Announc"},{"key":"2025010309481844400_dkae406-B27","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3389\/fimmu.2020.00303","article-title":"The rise of non-tuberculosis mycobacterial lung disease","volume":"11","author":"Ratnatunga","year":"2020","journal-title":"Front Immunol"},{"key":"2025010309481844400_dkae406-B28","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.3390\/pathogens12121446","article-title":"Differential immune responses and underlying mechanisms of metabolic reprogramming in smooth and rough variants of Mycobacterium peregrinum infections","volume":"12","author":"Lee","year":"2023","journal-title":"Pathogens"},{"key":"2025010309481844400_dkae406-B29","volume-title":"Mycobacterium chelonae Infection","author":"Akram","year":"2023"},{"key":"2025010309481844400_dkae406-B30","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1513\/AnnalsATS.201804-236OC","article-title":"Incidence and prevalence of nontuberculous mycobacterial lung disease in a large U.S. managed care health plan, 2008\u20132015","volume":"17","author":"Winthrop","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"2025010309481844400_dkae406-B31","doi-asserted-by":"publisher","first-page":"27","DOI":"10.3389\/fmed.2017.00027","article-title":"Infection sources of a common non-tuberculous mycobacterial pathogen, Mycobacterium avium complex","volume":"4","author":"Nishiuchi","year":"2017","journal-title":"Front Medicine"},{"key":"2025010309481844400_dkae406-B32","doi-asserted-by":"publisher","first-page":"TNMI7-0011-2016","DOI":"10.1128\/microbiolspec.TNMI7-0011-2016","article-title":"Mycobacterium kansasii","volume":"5","author":"Johnston","year":"2017","journal-title":"Microbiol Spectr"},{"key":"2025010309481844400_dkae406-B33","doi-asserted-by":"publisher","first-page":"e00363-20","DOI":"10.1128\/AAC.00363-20","article-title":"Rifabutin is bactericidal against intracellular and extracellular forms of Mycobacterium abscessus","volume":"64","author":"Johansen","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"2025010309481844400_dkae406-B34","doi-asserted-by":"publisher","first-page":"6977","DOI":"10.1128\/AAC.01291-16","article-title":"Bedaquiline targets the \u03b5 subunit of mycobacterial F-ATP synthase","volume":"60","author":"Subhashri","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2025010309481844400_dkae406-B35","doi-asserted-by":"publisher","first-page":"13295","DOI":"10.1002\/anie.202002546","article-title":"Discovery of a novel mycobacterial F-ATP synthase inhibitor and its potency in combination with diarylquinolines","volume":"59","author":"Hotra","year":"2020","journal-title":"Angew Chem Intl Ed Engl"},{"key":"2025010309481844400_dkae406-B36","doi-asserted-by":"publisher","first-page":"10276","DOI":"10.1074\/jbc.M110.200501","article-title":"Reduction of clofazimine by mycobacterial type 2 NADH:quinone oxidoreductase: a pathway for the generation of bactericidal levels of reactive oxygen species","volume":"286","author":"Yano","year":"2011","journal-title":"J Biol Chem"},{"key":"2025010309481844400_dkae406-B37","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1128\/AAC.00861-10","article-title":"Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing","volume":"55","author":"Bastian","year":"2011","journal-title":"Antimicrob Agents Chemother"},{"key":"2025010309481844400_dkae406-B38","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1128\/AAC.45.3.764-767.2001","article-title":"Activities of linezolid against rapidly growing mycobacteria","volume":"45","author":"Wallace","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"2025010309481844400_dkae406-B39","doi-asserted-by":"publisher","first-page":"e0079022","DOI":"10.1128\/aac.00790-22","article-title":"Strongly bactericidal all-oral \u03b2-lactam combinations for the treatment of Mycobacterium abscessus lung disease","volume":"66","author":"Negatu","year":"2022","journal-title":"Antimicrob Agents Chemother"},{"key":"2025010309481844400_dkae406-B40","doi-asserted-by":"publisher","first-page":"e0145922","DOI":"10.1128\/aac.01459-22","article-title":"Activity of oral tebipenem-avibactam in a mouse model of Mycobacterium abscessus lung infection","volume":"67","author":"Negatu","year":"2023","journal-title":"Antimicrob Agents Chemother"},{"key":"2025010309481844400_dkae406-B41","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s42003-020-01173-z","article-title":"Bedaquiline inhibits the yeast and human mitochondrial ATP synthases","volume":"3","author":"Luo","year":"2020","journal-title":"Comm Biol"},{"key":"2025010309481844400_dkae406-B42","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/s41586-024-07605-8","article-title":"Inhibition of M. tuberculosis and human ATP synthase by BDQ and TBAJ-587","volume":"631","author":"Zhang","year":"2024","journal-title":"Nature"},{"key":"2025010309481844400_dkae406-B43","doi-asserted-by":"publisher","first-page":"11945","DOI":"10.1073\/pnas.0711697105","article-title":"The protonmotive force is required for maintaining ATP homeostasis and viability of hypoxic, nonreplicating Mycobacterium tuberculosis","volume":"105","author":"Rao","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2025010309481844400_dkae406-B44","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1146\/annurev.micro.60.080805.142111","article-title":"DnaA: controlling the initiation of bacterial DNA replication and more","volume":"60","author":"Kaguni","year":"2006","journal-title":"Annu Rev Microbiol"},{"key":"2025010309481844400_dkae406-B45","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1002\/1873-3468.12739","article-title":"Crystallographic and solution structure of the N-terminal domain of the Rel protein from Mycobacterium tuberculosis","volume":"591","author":"Singal","year":"2017","journal-title":"FEBS Lett"},{"key":"2025010309481844400_dkae406-B46","doi-asserted-by":"publisher","first-page":"e0374923","DOI":"10.1128\/spectrum.03749-23","article-title":"Identification of genetic determinants of bedaquiline resistance in Mycobacterium tuberculosis in Ural region, Russia","volume":"12","author":"Umpeleva","year":"2024","journal-title":"Microbiol Spectr"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/1\/270\/60430206\/dkae406.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/80\/1\/270\/60430206\/dkae406.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,3]],"date-time":"2025-01-03T09:48:35Z","timestamp":1735897715000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/80\/1\/270\/7876338"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,5]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,11,5]]},"published-print":{"date-parts":[[2025,1,3]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkae406","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,1]]},"published":{"date-parts":[[2024,11,5]]}}}